Atricure to participate in the 39th annual j.p. morgan healthcare conference

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments for atrial fibrillation (afib) and left atrial appendage (laa) management, today announced that the company will be participating in the upcoming 39th annual j.p. morgan healthcare conference being held virtually. atricure's management is scheduled to present on monday, january 11, 2021, at 10:00 a.m. eastern time. interested parties may access a live audio webcast of the presentation by visi
ATRC Ratings Summary
ATRC Quant Ranking